Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12345678910...
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Acquired Cognitive Impairment 2019 NIA 5R01AG054029-02 The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease SPERLING, REISA BRIGHAM AND WOMEN'S HOSPITAL MA $3,981,411
Acquired Cognitive Impairment 2019 NIA 5R00AG047282-03 Insulin Resistance, Biomarkers of Brain Function, and Intermittent Calorie Restriction WILLETTE, AURIEL IOWA STATE UNIVERSITY IA $243,137
Acquired Cognitive Impairment 2019 NHLBI 1R35HL140027-01 Capillaries as a Sensory Web that Controls Cerebral Blood Flow in Health and Disease NELSON, MARK UNIVERSITY OF VERMONT & ST AGRIC COLLEGE VT $919,963
Acquired Cognitive Impairment 2019 NIA 1R21AG056007-01A1 Testing a Novel Approach to Solve the On-target, Off-site Effects of Alzheimer's Drugs LAHIRI, DEBOMOY INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $237,531
Acquired Cognitive Impairment 2019 NIA 5R01AG048252-04 Longitudinal Cognitive ERP studies: Advancement for AD Clinical Trials OLICHNEY, JOHN UNIVERSITY OF CALIFORNIA AT DAVIS CA $709,159
Acquired Cognitive Impairment 2019 NIA 5R01AG054059-03 African AMERICANS Fighting Alzheimer's In Midlife GLEASON, CAREY UNIVERSITY OF WISCONSIN-MADISON WI $757,573
Acquired Cognitive Impairment 2019 NIA 5R01AG040282-08 The ARIC-PET Amyloid Imaging Study GOTTESMAN, REBECCA JOHNS HOPKINS UNIVERSITY MD $716,095
Acquired Cognitive Impairment 2019 NIA 2P01AG027296-11 8588 Administrative and Leadership Core MOR, VINCENT BROWN UNIVERSITY RI $236,325
Acquired Cognitive Impairment 2019 NIA 2P01AG027296-11 8589 Pilot/Experimental Studies Core (PESC) BAIER, ROSA BROWN UNIVERSITY RI $252,332
Acquired Cognitive Impairment 2019 NIA 2P01AG027296-11 8590 Data Management and Methods Core (DM&M) GOZALO, PEDRO BROWN UNIVERSITY RI $854,877
Acquired Cognitive Impairment 2019 NIA 2P01AG027296-11 8591 Dementia as Disparity: Does ADRD Disadvantage Access to High Quality Post-Acute Care? MOR, VINCENT BROWN UNIVERSITY RI $285,676
Acquired Cognitive Impairment 2019 NIA 2P01AG027296-11 8592 Accountable Care for Persons with Advanced Dementia GOZALO, PEDRO BROWN UNIVERSITY RI $266,479
Acquired Cognitive Impairment 2019 NIA 2P01AG027296-11 8593 The Impact of Medicare Advantage on ADRD Care and Outcomes TRIVEDI, AMAL BROWN UNIVERSITY RI $314,419
Acquired Cognitive Impairment 2019 NIA 2P01AG027296-11 8594 Behavioral Control and Alzheimer's Disease: Policies, Medication Use, and Health Effects Across Care Settings SHIREMAN, THERESA BROWN UNIVERSITY RI $308,127
Acquired Cognitive Impairment 2019 NIEHS 5R01ES024165-05 Early and late-life metal exposures and Alzheimer's disease WEISSKOPF, MARC HARVARD SCHOOL OF PUBLIC HEALTH MA $863,598
Acquired Cognitive Impairment 2019 NIA 5U01NS100611-03 Lewy Body Dementia Biomarkers FREY, KIRK UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $410,661
Acquired Cognitive Impairment 2019 NIA 3R01AG050431-04S1 Characterizing novel hippocampal drugs for Alzheimer's disease PAHAN, KALIPADA RUSH UNIVERSITY MEDICAL CENTER IL $157,000
Acquired Cognitive Impairment 2019 NIA 5R01AG048349-04 PHASE II/III trial for Slowing Progression in Mild Cognitive Impairment GALLAGHER, MICHELA JOHNS HOPKINS UNIVERSITY MD $1,433,260
Acquired Cognitive Impairment 2019 NIA 5R21AG056882-02 Network-Level Mechanisms for Preclinical Alzheimer?s Disease Development LI, SHI-JIANG MEDICAL COLLEGE OF WISCONSIN WI $188,450
Acquired Cognitive Impairment 2019 NIA 5R01AG053938-03 Changes in arterial stiffness, cognition and dementia risk in a diverse cohort HEISS, GERARDO UNIV OF NORTH CAROLINA CHAPEL HILL NC $704,047
Acquired Cognitive Impairment 2019 NIA 5F31AG057150-02 Determining How Alzheimer's Disease Alters Hippocampal Network Signatures of Memory in Mouse Models JONES, EMILY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $36,998
Acquired Cognitive Impairment 2019 NIDA 5R21DA044886-02 Therapeutic potential of interferon (IFN)-beta for HIV-associated neurocognitive disorders (HAND) in opioid users CAO, LING UNIVERSITY OF NEW ENGLAND ME $160,983
Acquired Cognitive Impairment 2019 NIA 5R01AG048642-05 Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA) GONZALEZ, HECTOR UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $826,988
Acquired Cognitive Impairment 2019 NIA 5R01AG053972-03 Dementia Prevalence over Time: Proximate Causes and Consequences HURD, MICHAEL RAND CORPORATION CA $884,098
Acquired Cognitive Impairment 2019 NCCIH 5R61AT009628-02 Biological signatures of the cognitive effects of Centella asiatica SOUMYANATH, AMALA OREGON HEALTH & SCIENCE UNIVERSITY OR $301,951
Acquired Cognitive Impairment 2019 NIGMS 5U01GM098033-11 Structures and Propagation of Pathologically Relevant Amyloids in Alzheimer's ISHII, YOSHITAKA TOKYO INSTITUTE OF TECHNOLOGY JAPAN $289,331
Acquired Cognitive Impairment 2019 NIGMS 2P20GM109040-06 6133 Effect of Insulin on Neuroplasticity and Cognitive Rehabilitation ROBINSON, CATRINA MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $201,841
Acquired Cognitive Impairment 2019 NIGMS 2P20GM109040-06 6134 Neuromodulation of Cognitive Control Neurocircuits for Stroke Rehabilitation MCTEAGUE, LISA MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $201,841
Acquired Cognitive Impairment 2019 NIA 1K99AG059946-01 High-throughput optical investigation into intact large-scale nervous systems for Alzheimers disease REN, JIAN MASSACHUSETTS GENERAL HOSPITAL MA $137,160
Acquired Cognitive Impairment 2019 NIA 5F31AG058405-02 The intersection of Alzheimer’s disease and ribosome biogenesis through Amyloid Beta Precursor Protein Binding Family B Member 1 (APBB1; FE65) MCLEAN, LISA YALE UNIVERSITY CT $45,016
Acquired Cognitive Impairment 2019 NIA 5F31AG058473-02 Direct Proteasome Impairment by Neurotoxic Tau Oligomers ANDERSON, RAYMOND WEST VIRGINIA UNIVERSITY WV $45,016
Acquired Cognitive Impairment 2019 NIA 5F32AG058456-02 Vascular-associated neuroinflammation in Alzheimer's disease: differential effects on disease progression modulated by underlying amyloid burden BRAUN, DAVID UNIVERSITY OF KENTUCKY KY $61,610
Acquired Cognitive Impairment 2019 NIA 5F30AG055314-02 The Role of Cdk5 O-GlcNAcylation in Neurodegeneration and Alzheimer's Disease THOMPSON, JOHN CALIFORNIA INSTITUTE OF TECHNOLOGY CA $50,016
Acquired Cognitive Impairment 2019 NIA 5F32AG058352-02 Trends, Practice Variations, and Outcomes of Gastrostomy Tubes Placed during Critical Illness in the United States LAW, ANICA BETH ISRAEL DEACONESS MEDICAL CENTER MA $88,158
Acquired Cognitive Impairment 2019 NINDS 5F32NS096962-03 Investigating the contributions of neural competition to intentional forgetting and real-time neurofeedback WANG, TRACY UNIVERSITY OF TEXAS, AUSTIN TX $65,158
Acquired Cognitive Impairment 2019 NINDS 5F30NS090893-05 TDP-43-regulated microRNAs and TDP-43 Proteinopathy MCGEE, WARREN NORTHWESTERN UNIVERSITY AT CHICAGO IL $41,616
Acquired Cognitive Impairment 2019 NIGMS 5R01GM085179-08 The Role of RhoGTPases in Anesthetic-Mediated Neurotoxicity PATEL, PIYUSH VETERANS MEDICAL RESEARCH FDN/SAN DIEGO CA $286,921
Acquired Cognitive Impairment 2019 NIA 5R01NS095969-04 TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker WONG, PHILIP JOHNS HOPKINS UNIVERSITY MD $50,625
Acquired Cognitive Impairment 2019 NINDS 5R01NS095969-04 TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker WONG, PHILIP JOHNS HOPKINS UNIVERSITY MD $354,375
Acquired Cognitive Impairment 2019 NIA 5R01NS098243-03 Mechanistic studies and therapeutics for ALS-FTD linked to UBQLN2 mutations MONTEIRO, MERVYN UNIVERSITY OF MARYLAND BALTIMORE MD $88,266
Acquired Cognitive Impairment 2019 NINDS 5R01NS098243-03 Mechanistic studies and therapeutics for ALS-FTD linked to UBQLN2 mutations MONTEIRO, MERVYN UNIVERSITY OF MARYLAND BALTIMORE MD $416,115
Acquired Cognitive Impairment 2019 NIMH 5R01MH105329-05 Role of novel endolysosome-dependent calcium regulatory mechanisms in HAND GEIGER, JONATHAN UNIVERSITY OF NORTH DAKOTA ND $295,375
Acquired Cognitive Impairment 2019 NIA 5F32AG056098-02 Post-doctoral fellowship in the mechanisms of age-related tauopathy FARRELL, KURT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $64,169
Acquired Cognitive Impairment 2019 NINDS 5R01NS095441-04 Dietary sodium, neurovascular dysfunction and cerebrovascular risk IADECOLA, COSTANTINO WEILL MEDICAL COLL OF CORNELL UNIV NY $370,781
Acquired Cognitive Impairment 2019 NIA 5F32AG058457-02 Predictors and long-term health outcomes associated with cognitive and physical decline in older adults HANDING, ELIZABETH WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $64,731
Acquired Cognitive Impairment 2019 NIA 2RF1AG046860-06 Genetics of changes in population pyramids: Implications for health forecasting with a focus on Alzheimer's Disease and related dementias YASHIN, ANATOLIY DUKE UNIVERSITY NC $3,083,431
Acquired Cognitive Impairment 2019 NINDS 2R01NS083801-06 Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brain GREEN, KIM UNIVERSITY OF CALIFORNIA-IRVINE CA $373,512
Acquired Cognitive Impairment 2019 NINDS 5R01NS100782-02 Radiation-induced astrocyte dysfunction and cognitive decline UNGVARI, ZOLTAN UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $342,913
Acquired Cognitive Impairment 2019 NIMH 5R01MH084315-18 Mechanisms for Cognitive Dysfunction in Noonan Syndrome SILVA, ALCINO UNIVERSITY OF CALIFORNIA LOS ANGELES CA $433,525
Acquired Cognitive Impairment 2019 NIA 1K99AG057797-01A1 Association of blood-brain barrier breakdown with structural and molecular neuropathology in early Alzheimer's disease REAS, EMILIE UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $87,704
Acquired Cognitive Impairment 2019 NIDCD 5R01DC011492-09 Bilingual Alzheimer's Disease GOLLAN, TAMAR UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $447,848
Acquired Cognitive Impairment 2019 NIA 5F32AG058395-02 Cerebral Hemodynamics, Neurodegeneration, & Cognitive Aging OSBORN, KATIE VANDERBILT UNIVERSITY MEDICAL CENTER TN $61,610
Acquired Cognitive Impairment 2019 NIA 5F31AG058439-02 Drug Repositioning for ApoE4-Mediated Alzheimer's Disease TAUBES, ALICE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $36,932
Acquired Cognitive Impairment 2019 NINDS 5R35NS097275-03 Molecular Genetic Insight into Neurodegenerative Disease from Drosophila BONINI, NANCY UNIVERSITY OF PENNSYLVANIA PA $703,113
Acquired Cognitive Impairment 2019 NINDS 5R35NS097263-03 Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease GITLER, AARON STANFORD UNIVERSITY CA $1,027,273
Acquired Cognitive Impairment 2019 NCI 5R01CA129769-09 Older Breast Cancer Patients: Risk For Cognitive Decline MANDELBLATT, JEANNE GEORGETOWN UNIVERSITY DC $686,651
Acquired Cognitive Impairment 2019 NINDS 5R01NS099595-02 Molecular Mechanisms Underlying Obesity-related Memory Deficits ROBINSON, CATRINA MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $314,354
Acquired Cognitive Impairment 2019 NIA 5F31AG055331-03 Functional Properties of the Lateral Entorhinal Cortex in Learning and Aging LIN, CARMEN NORTHWESTERN UNIVERSITY AT CHICAGO IL $45,016
Acquired Cognitive Impairment 2019 NIA 5K24AG031155-09 Predictors of cognitive aging across the lifecourse YAFFE, KRISTINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $159,219
Acquired Cognitive Impairment 2019 NIGMS 5R01GM120484-03 The INSIGHT-ICU Study: Illuminating Neuropsychological dysfunction and Systemic Inflammatory mechanisms Gleaned after Hospitalization in Trauma-ICU Study PATEL, MAYUR VANDERBILT UNIVERSITY MEDICAL CENTER TN $641,663
Acquired Cognitive Impairment 2019 NINDS 5R01NS047229-14 Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and AD GEORGAKOPOULOS, ANASTASIOS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $370,781
Acquired Cognitive Impairment 2019 NIA 5K23AG055700-02 The Cognitive Disintegration Model of Delirium: A Clinical Cohort Study Investigating Neural Network Connectivity and Local Slow Wave Activity SANDERS, ROBERT UNIVERSITY OF WISCONSIN-MADISON WI $204,499
Acquired Cognitive Impairment 2019 NIA 5R03AG056189-02 Humanized mice as a model to study novel therapies for HIV-Associated Neurocognitive Disorders (HAND) in elderly HIV-1 infected individuals KELESIDIS, THEODOROS UNIVERSITY OF CALIFORNIA LOS ANGELES CA $78,000
Acquired Cognitive Impairment 2019 NCI 5R01CA213441-03 Therapeutic Irradiation and Brain Functions ROSI, SUSANNA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $344,237
Acquired Cognitive Impairment 2019 NIMH 5R37MH065635-18 Gene Expression in Long-Term Memory ALBERINI, CRISTINA NEW YORK UNIVERSITY NY $648,651
Acquired Cognitive Impairment 2019 NINDS 5R35NS097966-03 De novo Synthesis and Memory WORLEY, PAUL JOHNS HOPKINS UNIVERSITY MD $573,125
Acquired Cognitive Impairment 2019 NIEHS 5R01ES024936-05 Neurotoxicity of Airborne Particles: Role of Chronic Cerebral Hypoperfusion MACK, WILLIAM UNIVERSITY OF SOUTHERN CALIFORNIA CA $463,613
Acquired Cognitive Impairment 2019 NINDS 5R01NS102646-02 Multi-modal imaging of the mechanisms underlying impaired executive attention after traumatic brain injury KUCEYESKI, AMY WEILL MEDICAL COLL OF CORNELL UNIV NY $570,175
Acquired Cognitive Impairment 2019 NIGMS 5R01GM117552-35 High Resolution Characterization of Receptor Signaling and Regulation BAIRD, BARBARA CORNELL UNIVERSITY NY $380,284
Acquired Cognitive Impairment 2019 NIDDK 5R01DK064750-10 Microgial Iron Metabolism and Its Regulation by Cannabinoids WESSLING-RESNICK, MARIANNE HARVARD SCHOOL OF PUBLIC HEALTH MA $358,875
Acquired Cognitive Impairment 2019 NINDS 5R35NS097261-03 Genetic Discovery and Pathobiology of Frontotemporal Lobar Degeneration and Related TDP-43 Proteinopathies RADEMAKERS, ROSA MAYO CLINIC JACKSONVILLE FL $1,002,684
Acquired Cognitive Impairment 2019 NINDS 5R35NS097273-03 Expanding insights into FTD disease mechanisms PETRUCELLI, LEONARD MAYO CLINIC JACKSONVILLE FL $1,095,500
Acquired Cognitive Impairment 2019 NIA 5F31AG057174-02 Effects of Aging on the Selectivity of Attention and Memory DURBIN, KELLY UNIVERSITY OF SOUTHERN CALIFORNIA CA $45,016
Acquired Cognitive Impairment 2019 NIEHS 5R21ES027943-02 Impact of Second-Hand Smoke on Brain Metabolism and Cognition in Mice RABER, JACOB OREGON HEALTH & SCIENCE UNIVERSITY OR $193,749
Acquired Cognitive Impairment 2019 NINDS 5U01NS093334-04 Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors STERN, ROBERT BOSTON UNIVERSITY MEDICAL CAMPUS MA $2,226,344
Acquired Cognitive Impairment 2019 NIA 5F31AG056093-02 Characterizing the effects of vascular and genetic risk on brainstem white matter tract microstructure in older adults with mild cognitive impairment. WERHANE, MADELEINE UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $37,516
Acquired Cognitive Impairment 2019 NINDS 5R01NS038836-21 Anti-HIV-1 recall responses from brain-resident memory CD8+ T-cells (bTRM) and reactive gliosis-mediated neurotoxicity LOKENSGARD, JAMES UNIVERSITY OF MINNESOTA MN $385,000
Acquired Cognitive Impairment 2019 NINDS 5R21NS101386-02 Underlying Mechanisms of Cerebellar tDCS SAHIN, MESUT NEW JERSEY INSTITUTE OF TECHNOLOGY NJ $161,230
Acquired Cognitive Impairment 2019 NIA 5F32AG057107-02 Tracking Tau with In Vivo Braak Staging: Longitudinal Analysis of Tau Pathology and Functional Sequelae in Cognitively Healthy Older Adults HARRISON, THERESA UNIVERSITY OF CALIFORNIA BERKELEY CA $61,610
Acquired Cognitive Impairment 2019 NINDS 5R01NS089435-05 HIV-1 Tat genetic variation impacts NeuroAIDS NONNEMACHER, MICHAEL DREXEL UNIVERSITY PA $391,250
Acquired Cognitive Impairment 2019 NHLBI 5K99HL140106-02 Cerebral functional hyperemia responses induced by capillary NMDA receptors are disrupted by amyloid-beta accumulation PIRES, PAULO UNIVERSITY OF NEVADA RENO NV $649
Acquired Cognitive Impairment 2019 NINDS 5R01NS096465-04 Molecular Mechanisms of Microvascular Disease in Brain FARACI, FRANK UNIVERSITY OF IOWA IA $380,094
Acquired Cognitive Impairment 2019 NIA 5R01NS065244-09 Mechanisms of Prion Protein Toxicity HARRIS, DAVID BOSTON UNIVERSITY MEDICAL CAMPUS MA $111,449
Acquired Cognitive Impairment 2019 NINDS 5R01NS065244-09 Mechanisms of Prion Protein Toxicity HARRIS, DAVID BOSTON UNIVERSITY MEDICAL CAMPUS MA $525,401
Acquired Cognitive Impairment 2019 NINDS 5R33NS096032-03 Developing Novel RNA-Based Therapeutics for Parkinson's Disease MOURADIAN, M. MARAL RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL NJ $424,450
Acquired Cognitive Impairment 2019 NIGMS 5R01GM114260-04 Proteomics Approaches to Protein Turnover PENG, JUNMIN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $345,538
Acquired Cognitive Impairment 2019 NIDCD 2R01DC013063-06 Early Detection and Treatment of Emerging Cognitive-Linguistic Impairment in Minority Cognitive Aging and Primary Progressive Aphasia REILLY, JAMES TEMPLE UNIV OF THE COMMONWEALTH PA $438,611
Acquired Cognitive Impairment 2019 NIA 5R01AG051658-04 Advancing the Understanding of Postoperative Delirium Mechanisms via Multi-Omics MARCANTONIO, EDWARD BETH ISRAEL DEACONESS MEDICAL CENTER MA $485,512
Acquired Cognitive Impairment 2019 NIDCD 5R01DC016094-02 Translation and Clinical Implementation of a Test of Language and Short-term Memory (STM) in Aphasia MARTIN, NADINE TEMPLE UNIV OF THE COMMONWEALTH PA $655,355
Acquired Cognitive Impairment 2019 NCI 5R21CA223429-02 New Strategy for Pancreatic Cancer Therapy SOLHEIM, JOYCE UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $193,042
Acquired Cognitive Impairment 2019 NIA 5R01NS093382-04 Molecular Basis of Synaptic Suppression by ApoE HERZ, JOACHIM UT SOUTHWESTERN MEDICAL CENTER TX $50,520
Acquired Cognitive Impairment 2019 NINDS 5R01NS093382-04 Molecular Basis of Synaptic Suppression by ApoE HERZ, JOACHIM UT SOUTHWESTERN MEDICAL CENTER TX $354,480
Acquired Cognitive Impairment 2019 NINDS 5R01NS092045-05 The regulation of beta-amyloid sensitivity and Alzheimer's related impairments by PP2A ARANCIO, OTTAVIO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $350,000
Acquired Cognitive Impairment 2019 NIA 5R01AG046179-05 Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial BATEMAN, RANDALL WASHINGTON UNIVERSITY MO $5,316,057
Acquired Cognitive Impairment 2019 NINDS 5R01NS073613-09 Molecular-genetic dissection of basal forebrain circuitry regulating arousal FULLER, PATRICK BETH ISRAEL DEACONESS MEDICAL CENTER MA $380,625
Acquired Cognitive Impairment 2019 NINDS 5R01NS089575-04 Mechanisms underlying radiation-and chemotherapy induced cognitive impairment. LIMOLI, CHARLES UNIVERSITY OF CALIFORNIA-IRVINE CA $554,836
Acquired Cognitive Impairment 2019 NIA 5R01NS095793-04 Epigenetic Editing of Mutant C9orf72 LEE, EDWARD UNIVERSITY OF PENNSYLVANIA PA $50,000
Acquired Cognitive Impairment 2019 NINDS 5R01NS095793-04 Epigenetic Editing of Mutant C9orf72 LEE, EDWARD UNIVERSITY OF PENNSYLVANIA PA $423,444
Acquired Cognitive Impairment 2019 NINDS 5R01NS104934-02 Neural circuits for spatial navigation MAIMON, GABY ROCKEFELLER UNIVERSITY NY $423,750
Acquired Cognitive Impairment 2019 NHLBI 5R01HL042851-28 Hydrogen Sulfide in Newborn Cerebral Circulation PARFENOVA, HELENA UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $395,513
Acquired Cognitive Impairment 2019 NIMH 5R01MH104131-05 Lipocalin-2 in HIV-Associated Neuronal Injury KAUL, MARCUS UNIVERSITY OF CALIFORNIA RIVERSIDE CA $388,750
Acquired Cognitive Impairment 2019 NINDS 5R01NS093870-04 Recurrent Hemorrhagic Stroke in Minority Populations ROSAND, JONATHAN MASSACHUSETTS GENERAL HOSPITAL MA $554,637
Acquired Cognitive Impairment 2019 NINDS 5R25NS100134-03 Summer Research Experiences in Neurological Dysfunction TAGLIALATELA, GIULIO UNIVERSITY OF TEXAS MED BR GALVESTON TX $105,434
Acquired Cognitive Impairment 2019 NIA 5F30AG058317-02 Characterization of a Novel Mutation Associated with Vacuolar Tauopathy DARWICH, NABIL UNIVERSITY OF PENNSYLVANIA PA $31,967
Acquired Cognitive Impairment 2019 NIA 5K01AG047279-05 Pre-clinical testing of lenalidomide as pleiotropic therapeutics of Alzheimer's disease DECOURT, BORIS ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $5,498
Acquired Cognitive Impairment 2019 NIA 5R37AG032982-08 Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD) MITCHELL, SUSAN HEBREW REHABILITATION CENTER FOR AGED MA $826,001
Acquired Cognitive Impairment 2019 NIA 5R01AG049722-04 The contribution of declines in functional connectivity to cognitive aging BURKE, SARA UNIVERSITY OF FLORIDA FL $375,171
Acquired Cognitive Impairment 2019 NIA 5R21AG055943-02 Connecting Alzheimers Disease, APP, Circadian Regulation KRETZSCHMAR, DORIS OREGON HEALTH & SCIENCE UNIVERSITY OR $192,500
Acquired Cognitive Impairment 2019 NIA 5R01AG008441-27 Aging Memory SCHACTER, DANIEL HARVARD UNIVERSITY MA $422,500
Acquired Cognitive Impairment 2019 NIA 5R01AG055784-02 Characterizing the roles of novel soluble GSMs in AD pathology. ZHANG, CAN MASSACHUSETTS GENERAL HOSPITAL MA $425,945
Acquired Cognitive Impairment 2019 NIA 5R21AG057981-02 Pathogenic effects of plasma ApoE on CNS function and Alzheimer's disease LIU, CHIA-CHEN MAYO CLINIC JACKSONVILLE FL $195,625
Acquired Cognitive Impairment 2019 NIA 5R21AG058080-02 Dissecting the Role of HDAC6 in Alzheimer's Pathogenesis COHEN, TODD UNIV OF NORTH CAROLINA CHAPEL HILL NC $194,375
Acquired Cognitive Impairment 2019 NIA 5R21AG058109-02 The impact of aging on cancer-related cognitive comorbidities and mechanisms PYTER, LEAH OHIO STATE UNIVERSITY OH $194,030
Acquired Cognitive Impairment 2019 NIA 5K23AG057794-02 Investigation of molecular changes in mGluR5 and SV2A to study synaptic alterations in Alzheimer's disease using PET. MECCA, ADAM YALE UNIVERSITY CT $195,530
Acquired Cognitive Impairment 2019 NIGMS 5R01GM117191-05 Novel multiplexing proteomics to study the periphery in Alzheimer's disease ROBINSON, RENA VANDERBILT UNIVERSITY TN $307,322
Acquired Cognitive Impairment 2019 NIGMS 5R01GM125853-02 Molecular mechanisms of membrane disruption induced by early-stage aggregation of beta-amyloid peptides QIANG, WEI STATE UNIVERSITY OF NY,BINGHAMTON NY $247,952
Acquired Cognitive Impairment 2019 NHLBI 5K25HL131997-03 Quantitative characterization of human subcortical hemodynamic response KIM, JUNG HWAN BAYLOR COLLEGE OF MEDICINE TX $144,317
Acquired Cognitive Impairment 2019 NHLBI 5R01HL130237-04 Neurocognition, Lifestyle Modification, and Treatment Resistant Hypertension SMITH, PATRICK DUKE UNIVERSITY NC $295,748
Acquired Cognitive Impairment 2019 NINDS 5R37NS057553-13 Investigating Pathogenic Mechanisms of Frontotemporal Dementia Caused by Mutations in CHMP2B and TBK1 GAO, FEN-BIAO UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $594,625
Acquired Cognitive Impairment 2019 NINR 5R01NR016702-03 Reorientation Intervention for Delirium in the ICU MUNRO, CINDY UNIVERSITY OF MIAMI CORAL GABLES FL $470,681
Acquired Cognitive Impairment 2019 NIA 5R03AG058043-02 Relation of angiotensin converting enzyme (ACE) and angiotensin II (ANGII) to MRI volumetric measures from community based study YASAR, SEVIL JOHNS HOPKINS UNIVERSITY MD $81,875
Acquired Cognitive Impairment 2019 NIA 5R01AG052496-03 Emotion network dysfunction and decline in early frontotemporal dementia STURM, VIRGINIA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $547,169
Acquired Cognitive Impairment 2019 NIA 5R21AG058005-02 Mechanisms of beta-amyloid induced synaptic dysfunction KENNEDY, MATTHEW UNIVERSITY OF COLORADO DENVER CO $230,808
Acquired Cognitive Impairment 2019 NIA 5R01AG049752-04 A biomarker-driven trial of angiotensin receptor blockers for prodromal Alzheimer HAJJAR, IHAB EMORY UNIVERSITY GA $779,538
Acquired Cognitive Impairment 2019 NIA 5R01AG054473-03 Neuro-PET Radiotracer Discovery for Imaging Glycogen Synthase Kinase-3 VASDEV, NEIL MASSACHUSETTS GENERAL HOSPITAL MA $422,530
Acquired Cognitive Impairment 2019 NIA 5U01AG058499-02 Health and Retirement Study: Harmonized Cognitive Assessment Protocol (HCAP) LANGA, KENNETH UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $1,260,889
Acquired Cognitive Impairment 2019 NINDS 5R01NS100847-02 Molecular imaging of brain injury and repair in NFL players COUGHLIN, JENNIFER JOHNS HOPKINS UNIVERSITY MD $521,928
Acquired Cognitive Impairment 2019 NIA 5R01AG055413-02 Near infrared fluorescence imaging of reactive oxygen species in Alzheimer's disease RAN, CHONGZHAO MASSACHUSETTS GENERAL HOSPITAL MA $419,880
Acquired Cognitive Impairment 2019 NIA 5R01AG049084-04 Rhythm and Timing Exercises for Cerebral Vascular Disease in American Indians VERNEY, STEVEN UNIVERSITY OF NEW MEXICO NM $448,416
Acquired Cognitive Impairment 2019 NIA 5R03AG058100-02 Computational Design of Novel β-wrapins Targeting and Sequestering Amyloid-β, α-synuclein and IAPP TAMAMIS, PHANOURIOS TEXAS ENGINEERING EXPERIMENT STATION TX $69,483
Acquired Cognitive Impairment 2019 NIA 5R01AG049764-04 Cognitive training to protect immune systems of older caregivers HEFFNER, KATHI UNIVERSITY OF ROCHESTER NY $598,274
Acquired Cognitive Impairment 2019 NIA 5R21AG058111-02 Age-related decline in interactions between context, cognitive control, and memory WAGNER, ANTHONY STANFORD UNIVERSITY CA $196,250
Acquired Cognitive Impairment 2019 NIA 5R21AG055142-02 Imaging oxidative stress in an animal model of AD with PET MACH, ROBERT UNIVERSITY OF PENNSYLVANIA PA $201,250
Acquired Cognitive Impairment 2019 NIMH 5R01MH113406-03 Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60 VALCOUR, VICTOR UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $1,122,349
Acquired Cognitive Impairment 2019 NIA 5R01AG057746-02 Do State Regulations Affect the Outcomes of Assisted Living Residents with Dementia? THOMAS, KALI BROWN UNIVERSITY RI $656,400
Acquired Cognitive Impairment 2019 NIGMS 5R01GM101698-08 The Impact Of Surgery-Induced Neuroinflammation On Tau Pathology And Function WHITTINGTON, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $340,141
Acquired Cognitive Impairment 2019 NIA 5R01NS093097-04 Prefrontal AMPA receptors in FTD Pathogenesis YAO, WEI-DONG UPSTATE MEDICAL UNIVERSITY NY $83,523
Acquired Cognitive Impairment 2019 NINDS 5R01NS093097-04 Prefrontal AMPA receptors in FTD Pathogenesis YAO, WEI-DONG UPSTATE MEDICAL UNIVERSITY NY $393,754
Acquired Cognitive Impairment 2019 NIA 5K99AG057792-02 Studying methionine flux and its role in aging and neurodegeneration PARKHITKO, ANDREY HARVARD MEDICAL SCHOOL MA $98,754
Acquired Cognitive Impairment 2019 NIA 1R01AG060871-01 Microsimulation Modeling to Compare the Effectiveness and Cost-Effectiveness of Nondrug Interventions to Manage Clinical Symptoms in Racially/Ethnically Diverse Persons with Dementia JUTKOWITZ, ERIC BROWN UNIVERSITY RI $462,085
Acquired Cognitive Impairment 2019 NIMH 5R01MH106392-04 Progression of Attentional and Executive Function Deficits in HAND MACTUTUS, CHARLES UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $366,250
Acquired Cognitive Impairment 2019 NINDS 5R01NS099064-03 The role of amyloid precursor protein in HIV-1 replication and associated neurodegeneration NAGHAVI, MOJGAN NORTHWESTERN UNIVERSITY AT CHICAGO IL $420,169
Acquired Cognitive Impairment 2019 NIA 5R01AG033007-11 BRI2 Familial British and Danish Dementias and Alzheimer's Disease D'ADAMIO, LUCIANO RBHS-NEW JERSEY MEDICAL SCHOOL NJ $487,071
Acquired Cognitive Impairment 2019 NINDS 5R01NS093992-05 Targeting aberrant neurogenesis to prevent epilepsy and associated cognitive decline HSIEH, JENNY UNIVERSITY OF TEXAS SAN ANTONIO TX $326,396
Acquired Cognitive Impairment 2019 NIA 5R01AG047649-05 Novel Detection of Early Cognitive and Functional Impairment in the Elderly LOEWENSTEIN, DAVID UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $510,809
Acquired Cognitive Impairment 2019 NIGMS 5P41GM103622-23 8598 Core 1 Training pp.332-366 IRVING, THOMAS ILLINOIS INSTITUTE OF TECHNOLOGY IL $12,010
Acquired Cognitive Impairment 2019 NIGMS 5P41GM103622-23 8599 Core 2 Dissemination pp.367-405 IRVING, THOMAS ILLINOIS INSTITUTE OF TECHNOLOGY IL $52,681
Acquired Cognitive Impairment 2019 NIGMS 5P41GM103622-23 8605 Collaboration and Service pp.240-331 IRVING, THOMAS ILLINOIS INSTITUTE OF TECHNOLOGY IL $236,893
Acquired Cognitive Impairment 2019 NIGMS 1R35GM130331-01 GOLGI BIOGENESIS AND FUNCTION WANG, YANZHUANG UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $465,587
Acquired Cognitive Impairment 2019 NCCIH 5R21AT009734-02 Increasing dietary choline to prevent chemotherapy-related cognitive deficits PHILPOT, REX UNIVERSITY OF SOUTH FLORIDA FL $186,875
Acquired Cognitive Impairment 2019 NIMH 5R01MH060013-20 Neuromodulation and Cortical Memory Function HASSELMO, MICHAEL BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) MA $409,250
Acquired Cognitive Impairment 2019 NIGMS 5SC3GM116667-04 Identification and confirmation of blood-brain barrier (BBB) permeability of chemical enhancers of nerve growth factor-dependent neurite outgrowth. IBEANU, GORDON NORTH CAROLINA CENTRAL UNIVERSITY NC $108,000
Acquired Cognitive Impairment 2019 NIA 5R01NS096730-04 CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION GREENBERG, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $113,046
Acquired Cognitive Impairment 2019 NINDS 5R01NS096730-04 CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION GREENBERG, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $1,020,620
Acquired Cognitive Impairment 2019 NINDS 5R01NS041783-18 Presenilins in the hippocampal network and Alzheimer's disease SHEN, JIE BRIGHAM AND WOMEN'S HOSPITAL MA $651,134
Acquired Cognitive Impairment 2019 NINDS 5R01NS096012-04 Rewiring the injured brain with GABA progenitors. HUNT, ROBERT UNIVERSITY OF CALIFORNIA-IRVINE CA $337,969
Acquired Cognitive Impairment 2019 NIMH 5R01MH112151-03 Characterization of SynGAP Mutations in Human Cognitive Disorders HUGANIR, RICHARD JOHNS HOPKINS UNIVERSITY MD $528,913
Acquired Cognitive Impairment 2019 OD 5R24OD023076-03 Development of marmoset models of neurodegenerative disease using embryonic stem cell-based gene-editing approaches LEE, KUO-FEN SALK INSTITUTE FOR BIOLOGICAL STUDIES CA $728,786
Acquired Cognitive Impairment 2019 NIA 5R01AG049002-05 Noninvasive Stimulation to Improve Hippocampal-Dependent Memory in Older Adults VOSS, JOEL NORTHWESTERN UNIVERSITY AT CHICAGO IL $468,832
Acquired Cognitive Impairment 2019 NIA 7R01AG047500-05 Predictors of Late-life Cognitive Health in Type 1 Diabetes WHITMER, RACHEL UNIVERSITY OF CALIFORNIA AT DAVIS CA $590,746
Acquired Cognitive Impairment 2019 NIA 5R01AG049953-05 A life course approach to integrating trauma and cognitive aging: A cohort of 9/11 responders CLOUSTON, SEAN STATE UNIVERSITY NEW YORK STONY BROOK NY $585,555
Acquired Cognitive Impairment 2019 NIA 5R01AG050598-04 Mechanisms transducing insulin and insulin resistance in the hippocampus MCNAY, EWAN STATE UNIVERSITY OF NEW YORK AT ALBANY NY $379,882
Acquired Cognitive Impairment 2019 NIA 5R01AG050716-04 The Nicotinic Cholinergic System and Cognitive Aging DUMAS, JULIE UNIVERSITY OF VERMONT & ST AGRIC COLLEGE VT $372,867
Acquired Cognitive Impairment 2019 NIA 5R01AG052286-04 Mechanisms of APP and APLP2 function at synapses D'ADAMIO, LUCIANO RBHS-NEW JERSEY MEDICAL SCHOOL NJ $686,386
Acquired Cognitive Impairment 2019 NIMH 5R01MH109719-04 Inhibitor-2 is a positive regulator for PP1's synaptic and cognitive functions XIA, HOUHUI UNIVERSITY OF ROCHESTER NY $385,000
Acquired Cognitive Impairment 2019 NIA 5R01AG048927-05 Alzheimer Disease Genetic Architecture in African Americans FARRER, LINDSAY BOSTON UNIVERSITY MEDICAL CAMPUS MA $537,696
Acquired Cognitive Impairment 2019 NIMH 5R01MH107570-04 Biochemical and Synaptic Mechanisms in Prefrontal Cortex and Vulnerability for Cognitive Deficits ELSWORTH, JOHN YALE UNIVERSITY CT $622,532
Acquired Cognitive Impairment 2019 NIMH 5R01MH110246-04 Dysregualtion of gliotransmission in models of neuroHIV HAUGHEY, NORMAN JOHNS HOPKINS UNIVERSITY MD $405,000
Acquired Cognitive Impairment 2019 NIA 5R01NS096785-09 Integrating Quality Control: Studies of UBQLN2 in Age-Related Neurodegeneration PAULSON, HENRY UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $37,432
Acquired Cognitive Impairment 2019 NINDS 5R01NS096785-09 Integrating Quality Control: Studies of UBQLN2 in Age-Related Neurodegeneration PAULSON, HENRY UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $642,759
Acquired Cognitive Impairment 2019 NIA 5R01AG033040-10 MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults AU, RHODA BOSTON UNIVERSITY MEDICAL CAMPUS MA $1,004,154
Acquired Cognitive Impairment 2019 NIA 5R21AG057997-02 Impact of APOE3 and APOE4 on the peripheral immune system in Alzheimer's disease KANG, SILVIA MAYO CLINIC JACKSONVILLE FL $195,625
Acquired Cognitive Impairment 2019 NIA 5R01AG049899-05 Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study QIU, WEI QIAO BOSTON UNIVERSITY MEDICAL CAMPUS MA $335,585
Acquired Cognitive Impairment 2019 NIA 2P01AG003991-36 8859 Core A: Administration Core MORRIS, JOHN WASHINGTON UNIVERSITY MO $190,929
Acquired Cognitive Impairment 2019 NIA 2P01AG003991-36 8860 Core B: Clinical Core MORRIS, JOHN WASHINGTON UNIVERSITY MO $816,012
Acquired Cognitive Impairment 2019 NIA 2P01AG003991-36 8861 Core C: Biostatistics Core XIONG, CHENGJIE WASHINGTON UNIVERSITY MO $189,556
Acquired Cognitive Impairment 2019 NIA 2P01AG003991-36 8862 Core D: Neuropathology Core PERRIN, RICHARD WASHINGTON UNIVERSITY MO $470,412
Acquired Cognitive Impairment 2019 NIA 2P01AG003991-36 8863 Core E: Imaging Core BENZINGER, TAMMIE WASHINGTON UNIVERSITY MO $1,130,092
Acquired Cognitive Impairment 2019 NIA 2P01AG003991-36 8864 Characterization of molecular biomarker profiles of AD throughout its pathobiolgical continuum MORRIS, JOHN WASHINGTON UNIVERSITY MO $148,555
Acquired Cognitive Impairment 2019 NIA 2P01AG003991-36 8865 Sleep and Orexin: Potential Markers of Progression from Preclinical to Mildly Symptomatic Alzheimer's Disease LUCEY, BRENDAN WASHINGTON UNIVERSITY MO $202,155
Acquired Cognitive Impairment 2019 NIA 2P01AG003991-36 8866 Dissecting the Genetic Architecture of Cognitive Reserve and Resilience CRUCHAGA, CARLOS WASHINGTON UNIVERSITY MO $187,962
Acquired Cognitive Impairment 2019 NIA 2P01AG003991-36 8867 Smartphone-Based "Burst" Cognitive Assessments HASSENSTAB, JASON WASHINGTON UNIVERSITY MO $326,518
Acquired Cognitive Impairment 2019 NIA 3P01AG025204-13S1 Imaging Pathophysiology in Aging and NeurodegenerationProject-5: Image Quantitation Enhancement for Amyloid and Tau PET KLUNK, WILLIAM UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $156,679
Acquired Cognitive Impairment 2019 NIDA 5K23DA042946-03 Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents SCHUSTER, RANDI MASSACHUSETTS GENERAL HOSPITAL MA $200,560
Acquired Cognitive Impairment 2019 NIGMS 5R01GM097562-08 Mimicry of Amyloid Oligomers NOWICK, JAMES UNIVERSITY OF CALIFORNIA-IRVINE CA $291,405
Acquired Cognitive Impairment 2019 NIGMS 1P20GM125528-01A1 5337 Translational analysis of cerebrovascular dysfunction in aging YABLUCHANSKIY, ANDRIY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $261,000
Acquired Cognitive Impairment 2019 NIGMS 1P20GM130459-01 5456 Heterogeneity of blood flow distribution in cortex and the involvement of global long-range neuromodulatory projections TRAN, CAM HA UNIVERSITY OF NEVADA RENO NV $227,366
Acquired Cognitive Impairment 2019 NIA 1R01AG060920-01 RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY MARADIT KREMERS, HILAL MAYO CLINIC ROCHESTER MN $658,294
Acquired Cognitive Impairment 2019 NIA 1R01AG060919-01 Oxidation of K+ channels mediates an amyloidogenic pathway common to Alzheimer's disease and TBI SESTI, FEDERICO RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL NJ $397,500
Acquired Cognitive Impairment 2019 NINDS 5R01NS091336-05 Serine/Threonine Phosphatases in Neurological Diseases PETI, WOLFGANG UNIVERSITY OF ARIZONA AZ $333,353
Acquired Cognitive Impairment 2019 NINDS 5R01NS023945-27 AFFERENT REGULATION OF CHOLINERGIC FOREBRAIN NEURONS ZABORSZKY, LASZLO RUTGERS THE STATE UNIV OF NJ NEWARK NJ $413,389
Acquired Cognitive Impairment 2019 NIA 3P50AG008702-29S3 6385 Creating a human microglial sample resource for the Alzheimer's Disease community DE JAGER, PHILIP COLUMBIA UNIVERSITY HEALTH SCIENCES NY $385,701
Acquired Cognitive Impairment 2019 NIGMS 1P20GM125526-01A1 6478 Impact of APOE and FOXO3 Genotype on Hemorrhagic Stroke in Japanese-American Men NAKAGAWA, KAZUMA KUAKINI MEDICAL CENTER HI $212,783
Acquired Cognitive Impairment 2019 NIGMS 5R01GM072611-14 Statistical Methods for Ultrahigh-dimensional Biomedical Data FAN, JIANQING PRINCETON UNIVERSITY NJ $293,003
Acquired Cognitive Impairment 2019 NINDS 5R01NS088322-05 Propagation of Lewy pathology in Parkinsons disease LUK, KELVIN UNIVERSITY OF PENNSYLVANIA PA $350,000
Acquired Cognitive Impairment 2019 NIA 1R01NS108958-01 Activity-Dependent Regulation of Kv4 Channels TSUNODA, SUSAN COLORADO STATE UNIVERSITY CO $36,223
Acquired Cognitive Impairment 2019 NINDS 1R01NS108958-01 Activity-Dependent Regulation of Kv4 Channels TSUNODA, SUSAN COLORADO STATE UNIVERSITY CO $29,322
Acquired Cognitive Impairment 2019 NINDS 5R01NS073899-09 The hsp90 Cochaperone FKBP51 Regulates tau Structure and Function KANG, DAVID UNIVERSITY OF SOUTH FLORIDA FL $483,054
Acquired Cognitive Impairment 2019 NIA 5R01AG050263-05 NOVEL PET TRACERS FOR IMAGING OF ALZHEIMER'S DISEASE SHARMA, VIJAY WASHINGTON UNIVERSITY MO $312,625
Acquired Cognitive Impairment 2019 NIA 5K25AG050759-04 The influence of multi-domain cognitive training on large-scale structural and functional brain networks in MCI HOSSEINI, SEYED STANFORD UNIVERSITY CA $147,090
Acquired Cognitive Impairment 2019 NIA 5P01AG014449-21 Neurobiology of Mild Cognitive Impairment MUFSON, ELLIOTT ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER AZ $1,681,922
Acquired Cognitive Impairment 2019 NIA 5R01AG049750-04 Estimating Long-Term Disease Trajectories from Short-Term Data DONOHUE, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $404,687
Acquired Cognitive Impairment 2019 NICHD 5R01HD079568-05 MICROBLEEDS AS A MARKER OF RADIATION-INDUCED BRAIN INJURY IN PEDIATRIC PATIENTS LUPO, JANINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $498,433
Acquired Cognitive Impairment 2019 NIA 1R01AG060929-01 Using Twitter to Enhance the Social Support of Hispanic and Black Dementia Caregivers (Tweet-SS) YOON, SUNMOO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $573,557
Acquired Cognitive Impairment 2019 NEI 1R01EY029663-01 Bi-directional, task-dependent control of thalamic input gain, in layer 4c of the primary visual cortex, by the cholinergic and serotonergic neuromodulatory systems. DISNEY, ANITA DUKE UNIVERSITY NC $390,479
Acquired Cognitive Impairment 2019 NIA 1RF1AG060939-01 Antipsychotic reduction in nursing home residents with Alzheimer's disease: Impact on state, facility, and resident psychopharmacological medication use and outcomes SIMONI-WASTILA, LINDA UNIVERSITY OF MARYLAND BALTIMORE MD $1,597,610
Acquired Cognitive Impairment 2019 NIA 1R01AG060935-01 Improving the Quality of Care Provided Through Bundled Payments for Patients with Alzheimer's Disease or Other Forms of Dementia or Frailty EPSTEIN, ARNOLD HARVARD SCHOOL OF PUBLIC HEALTH MA $826,366
Acquired Cognitive Impairment 2019 NIA 1R01AG060933-01 The role of personality in cognitive aging and dementia SCOTT, STACEY STATE UNIVERSITY NEW YORK STONY BROOK NY $463,114
Acquired Cognitive Impairment 2019 NICHD 5F30HD086975-03 Modeling Down Syndrome Neural Phenotypes with Chromosomal Silencing CZERMINSKI, JAN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $31,720
Acquired Cognitive Impairment 2019 NICHD 5R01HD086977-04 Tau/P-Tau as Biomarkers of Anesthesia- and Surgery-Induced Cognitive Impairment in a Murine Model XIE, ZHONGCONG MASSACHUSETTS GENERAL HOSPITAL MA $365,461
Acquired Cognitive Impairment 2019 NIA 1R01AG060993-01 Automating Delirium Identification and Risk Prediction in Electronic Health Records KENNEDY, RICHARD UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $432,969
Acquired Cognitive Impairment 2019 NIA 1R01AG061384-01 Improving the statistical design and analysis of randomized controlled trials of delirium prevention and treatment for critically ill older adults COLANTUONI, ELIZABETH JOHNS HOPKINS UNIVERSITY MD $404,423
Acquired Cognitive Impairment 2019 NIDCD 1R01DC017437-01 Odor Memory Traces in the Mouse Olfactory Cortex FLEISCHMANN, ALEXANDER BROWN UNIVERSITY RI $373,548
Acquired Cognitive Impairment 2019 NIA 1R01AG061038-01 Sporadic Alzheimer's Disease: A Bioenergetic Etiology? ZHAO, LIQIN UNIVERSITY OF KANSAS LAWRENCE KS $370,934
Acquired Cognitive Impairment 2019 NIA 1R01AG060987-01 Treating hyperexcitability in Alzheimer’s disease with levetiracetam to improve brain function and cognition SHAFI, MOUHSIN BETH ISRAEL DEACONESS MEDICAL CENTER MA $571,143
Acquired Cognitive Impairment 2019 NICHD 5R01HD064993-10 Aging and Dementia in Down Syndrome: Connectivity, Inflammation, and Cerebrovascular Contributions SCHMITT, FREDERICK UNIVERSITY OF KENTUCKY KY $527,486
Acquired Cognitive Impairment 2019 NIA 1R01AG061383-01 MicroRNAs in CNS-derived extracellular microvesicles as peripheral blood biomarkers for Alzheimer disease SHI, MIN UNIVERSITY OF WASHINGTON WA $675,268
Acquired Cognitive Impairment 2019 NIA 5R01AG022983-13 Decision-Making in Genetic FTD CHIONG, WINSTON UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $724,672
Acquired Cognitive Impairment 2019 NIGMS 5R01GM062882-18 Cholesterol Metabolizing P450s; structure and function PIKULEVA, IRINA CASE WESTERN RESERVE UNIVERSITY OH $388,325
Acquired Cognitive Impairment 2019 NIMH 5R01MH109466-04 Age-Related Histone Modification Effect on Antipsychotic Action DONG, HONGXIN NORTHWESTERN UNIVERSITY AT CHICAGO IL $386,250
Acquired Cognitive Impairment 2019 NIMH 5P30MH062512-19 7775 Neurobiology Core ACHIM, CRISTIAN UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $122,521
Acquired Cognitive Impairment 2019 NIA 5R01NS050915-15 Primary Progressive Aphasia: Cognition, Anatomy and Progression GORNO TEMPINI, MARIA LUISA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $136,269
Acquired Cognitive Impairment 2019 NINDS 5R01NS050915-15 Primary Progressive Aphasia: Cognition, Anatomy and Progression GORNO TEMPINI, MARIA LUISA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $648,133
Acquired Cognitive Impairment 2019 NIA 1RF1AG061035-01 Antimicrobial activities of Abeta in Alzheimer's disease brain MOIR, ROBERT MASSACHUSETTS GENERAL HOSPITAL MA $3,229,539
Acquired Cognitive Impairment 2019 NIA 1R01AG060981-01 Gamma Induction for Amyloid Clearance in Alzheimer’s Disease SANTARNECCHI, EMILIANO BETH ISRAEL DEACONESS MEDICAL CENTER MA $649,289
Acquired Cognitive Impairment 2019 NIA 1RF1AG060977-01 Metabolic Interventions for Enhancing Cognitive Resilience in Aging and Alzheimers Disease BURKE, SARA UNIVERSITY OF FLORIDA FL $1,916,469
Acquired Cognitive Impairment 2019 NIA 1R01AG061132-01 Interpretable Machine Learning to Identify Alzheimer's Disease Therapeutic Targets LEE, SU-IN UNIVERSITY OF WASHINGTON WA $582,016
Acquired Cognitive Impairment 2019 NIA 1R01AG060967-01 Home, but homebound: The impact of caregiving, financial, and community resources on the lives of individuals with dementia ORNSTEIN, KATHERINE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $423,750
Acquired Cognitive Impairment 2019 NIA 1R01AG061028-01 Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD) DAMS-O'CONNOR, KRISTEN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $1,185,575
Acquired Cognitive Impairment 2019 NIA 1RF1AG061127-01 Building blood based DNA methylation signatures for AD that are reflective of CNS changes WANG, LILY UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $1,918,750
Acquired Cognitive Impairment 2019 NIA 1RF1NS109157-01 Examining the role of glycosphingolipids in the progression and heterogeneity of synucleinopathies MAZZULLI, JOSEPH NORTHWESTERN UNIVERSITY AT CHICAGO IL $1,928,426
Acquired Cognitive Impairment 2019 NIA 1RF1AG061022-01 Neurocognitive aging, MCI and Alzheimer's disease DNA methylation among diverse Latinos GONZALEZ, HECTOR UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $6,630,354
Acquired Cognitive Impairment 2019 NIA 1RF1AG061355-01 The Impact of Sex Hormones on Sleep-Dependent Memory in Young and Midlife Men and Women BAKER, FIONA SRI INTERNATIONAL CA $4,815,989
Acquired Cognitive Impairment 2019 NIA 5R01AG049810-04 Re-visiting Methods for MCI Diagnosis to Improve Biomarker and Trial Findings BONDI, MARK UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $747,680
Acquired Cognitive Impairment 2019 NIA 1U01AG060965-01 IND-enabling Preclinical Studies on Anti-Tau AD Vaccine for Phase 1 Trial AGADJANYAN, MICHAEL INSTITUTE FOR MOLECULAR MEDICINE CA $1,116,260
Acquired Cognitive Impairment 2019 NIA 1R01AG061447-01 Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease WEI, HUAFENG UNIVERSITY OF PENNSYLVANIA PA $402,500
Acquired Cognitive Impairment 2019 NIA 1R01AG061122-01 Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects DIDSBURY, JOHN T3D THERAPEUTICS, INC. NC $2,292,799
Acquired Cognitive Impairment 2019 NIA 1R01AG061120-01 Iron as an Imaging Biomarker for Inflammation in AD ZEINEH, MICHAEL STANFORD UNIVERSITY CA $714,464
Acquired Cognitive Impairment 2019 NHLBI 5R01HL135144-03 Mitochondrial Determinants of Cognitive Outcomes in ARDS and Sepsis GIRARD, TIMOTHY UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $374,354
Acquired Cognitive Impairment 2019 NHLBI 5R01HL138685-02 Genetic determinants of hypertension-induced cerebral vascular dysfunction ROMAN, RICHARD UNIVERSITY OF MISSISSIPPI MED CTR MS $486,423
Acquired Cognitive Impairment 2019 NINDS 5R01NS097818-03 Clinically unscreened vasculo-glial-neuronal coupling is critical for physiological brain function FILOSA, JESSICA AUGUSTA UNIVERSITY GA $332,500
Acquired Cognitive Impairment 2019 NINDS 5R03NS103000-02 Mapping Brain-Cognition Relationships which Encode Cognitive Deficits in Refractory Epilepsy JAMES, GEORGE UNIV OF ARKANSAS FOR MED SCIS AR $77,920
Acquired Cognitive Impairment 2019 NIDA 1R01DA047410-01 A novel phase and spectroscopic imaging technique to evaluate mitochondrial dynamics KHMALADZE, ALEXANDER STATE UNIVERSITY OF NEW YORK AT ALBANY NY $366,011
Acquired Cognitive Impairment 2019 NIA 1R01AG061116-01 Efficacy of the WeCareAdvisor: An Online Tool to Help Caregivers Manage Behavioral and Psychological Symptoms in Persons with Dementia GITLIN, LAURA DREXEL UNIVERSITY PA $811,633
Acquired Cognitive Impairment 2019 NIA 1R01AG061114-01 Deciphering molecular mechanisms that underlie brain endothelial cell dysfunction with APOE4 TAI, LEON UNIVERSITY OF ILLINOIS AT CHICAGO IL $467,440
Acquired Cognitive Impairment 2019 NIA 1R01AG061111-01 Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArT–HS) JICHA, GREGORY UNIVERSITY OF KENTUCKY KY $763,006
Acquired Cognitive Impairment 2019 NIA 1RF1AG061206-01 Postmortem validation of novel tau PET tracers GOMEZ-ISLA, TERESA MASSACHUSETTS GENERAL HOSPITAL MA $2,887,030
Acquired Cognitive Impairment 2019 NIA 1R01AG061303-01 New Statistical Methods for Multicenter Multimodal Longitudinal Neuroimaging Analysis LI, LEXIN UNIVERSITY OF CALIFORNIA BERKELEY CA $371,002
Acquired Cognitive Impairment 2019 NIA 1R01AG061518-01 Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease HOHMAN, TIMOTHY VANDERBILT UNIVERSITY MEDICAL CENTER TN $900,827
Acquired Cognitive Impairment 2019 NIA 1RF1AG061351-01 Functional genetic analyses of existing data resources to expand AD gene discovery BELOW, JENNIFER VANDERBILT UNIVERSITY MEDICAL CENTER TN $3,002,657
12345678910...


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer